Nuclein, LLC
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-08-148/14/26 | Amended | $9,253,488 | $7,958,488 | Debt Only | 06b | SEC linkSEC |
| 2026-06-226/22/26 | New | $1,295,000 | $1,295,000 | Debt Only | 06b | SEC linkSEC |
| 2026-04-274/27/26 | Amended | $19,065,157 | $4,161,157 | Debt Only | 06b | SEC linkSEC |
| 2026-02-052/5/26 | Amended | $9,392,180 | Unknown | Equity Only | SEC linkSEC | |
| 2025-12-1712/17/25 | Amended | $14,904,000 | $5,125,000 | Debt Only | 06b | SEC linkSEC |
| 2025-10-1410/14/25 | Amended | $9,779,000 | $9,779,000 | Debt Only | 06b | SEC linkSEC |
| 2025-06-306/30/25 | New | Yet to Sell | $0 | Debt Only | 06b | SEC linkSEC |
| 2025-02-032/3/25 | New | $750,000 | $750,000 | Equity Only | 06b | SEC linkSEC |
| 2024-08-058/5/24 | Amended | $8,788,151 | $8,788,151 | Debt Only | 06b | SEC linkSEC |
| 2023-11-1711/17/23 | New | Yet to Sell | $0 | Debt Only | 06b | SEC linkSEC |
| 2023-03-233/23/23 | New | Yet to Sell | $0 | Equity Only | 06b | SEC linkSEC |
| 2022-07-127/12/22 | New | Yet to Sell | $0 | Equity Only | 06b | SEC linkSEC |
| 2021-01-191/19/21 | New | Yet to Sell | $0 | Equity Only | 06b | SEC linkSEC |
| 2020-02-182/18/20 | New | Yet to Sell | $0 | Debt Only | 06b | SEC linkSEC |
| 2019-09-109/10/19 | New | $420,012 | $420,012 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Alan Blake | Director, Executive |
| Douglas Bryant | Director |
| John Butler | Director |
| Sanjay Chandra | Director |
| Richard Crockett | Director |
| William Cunningham | Director |
| Walter Narajowski | Director |
| David Shockley | Director |
| H. David Shockley | Director |
| Jeffrey Stukuls | Executive |
Industry: Biotechnology (See others in industry)
Address:
8305 Cross Park Dr
Austin, TX, 78754
Phone: 512-879-3301
Austin, TX, 78754
Phone: 512-879-3301